Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

719
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
719
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

15
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

12
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
12

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Early Initiation of Continuous Renal Replacement Therapy in Neonatal Extracorporeal Life Support: A 17-Year Retrospective Review.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Identifying Early Predictive Factors of Unexpected Clinical Deterioration in Postoperative Pediatric Surgical Patients.

Dimensions of critical care nursing : DCCN·2026
Same author

Increased mortality in children with severe trauma and bleeding: Hypotheses and methods to reduce the risk.

Transfusion·2026
Same author

Consensus-based criteria for actionable hemorrhage in pediatric trauma: A Delphi study.

The journal of trauma and acute care surgery·2026
Same author

Type 1 Dolichocolon as a Potential Anatomic Co-morbidity in Children with Perianal Crohn's Disease.

Digestive diseases and sciences·2026
Same author

Hospital variation in postoperative mortality among preterm infants.

Journal of pediatric surgery·2026
Same journal

The EXTra-uterine Environment for Neonatal Development (EXTEND) - future treatment for prematurity and potentially other congenital disease.

Seminars in pediatric surgery·2026
Same journal

Appendicitis as a model for pediatric surgical quality improvement and standardization.

Seminars in pediatric surgery·2026
Same journal

From FOB to PICU: military trauma systems that changed pediatrics.

Seminars in pediatric surgery·2026
Same journal

Long-term follow-up after surgery for congenital anomalies: A time to complication analysis.

Seminars in pediatric surgery·2026
Same journal

Radio-surgical decision-making in hepatoblastoma in the post-PHITT era: SIOPEL consensus recommendations.

Seminars in pediatric surgery·2026
Same journal

Seminars in pediatric sugery pediatric metabolic and bariatric surgery.

Seminars in pediatric surgery·2026
查看所有相关文章

相关实验视频

Updated: Jul 11, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.5K

在ECMO中使用全身抗凝剂.

Shannon M Larabee1, Laura E Hollinger2, Adam M Vogel1

  • 1Texas Children's Hospital and Baylor College of Medicine, United States.

Seminars in pediatric surgery
|November 15, 2023
PubMed
概括
此摘要是机器生成的。

未分离的氨酸 (UFH) 和直接的血栓抑制剂 (DTI) 是儿科外体生命支持 (ECMO) 的关键抗凝剂. 本综述详细介绍了它们的使用,监测和指导方针,并指出儿童ECMO抗凝药缺乏共识.

关键词:
激活的凝血时间激活的部分血栓塑时间.抗 Xa 抗 Xa 是一种抗 Xa 的方法.这是一种抗凝血药物.稀释的血栓激素时间身体外膜氧化器的氧化氨酸,直接的血栓激素抑制剂粘弹性测定 粘弹性测定

更多相关视频

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

317
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

639

相关实验视频

Last Updated: Jul 11, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.5K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

317
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

639

科学领域:

  • 儿科重症监护医药 儿科重症监护医药
  • 血液学 血液学 血液学
  • 进行心血管外科手术.

背景情况:

  • 未分离的肝素 (UFH) 是儿科外体生命支持 (ECMO) 的标准抗凝剂.
  • 直接血栓抑制剂 (DTI) 越来越多地被用作替代品或辅助剂.
  • 在儿科ECMO中最佳的抗凝管理仍然具有挑战性,因为证据有限,实践不断变化.

研究的目的:

  • 审查目前关于UFH和DTI在儿科ECMO中使用的证据.
  • 为了比较UFH和DTI的优缺点.
  • 概述抗凝血监测策略和儿科ECMO的最新指导方针.

主要方法:

  • 关于UFH和DTI在儿科ECMO中使用的最新证据的文献综述.
  • 抗凝剂特性,疗效和安全性资料的比较.
  • 分析体外生命支持组织 (ELSO) 准则和常见的临床实践.

主要成果:

  • 在儿科ECMO中,UFH和DTI提供了不同的好处和风险.
  • 有效的抗凝血监测对于患者的安全至关重要.
  • 目前的指导方针提供了一个框架,但对于儿科ECMO抗凝药缺乏共识.

结论:

  • 对UFH和DTI使用的基于证据的审查支持儿科ECMO的知情临床决策.
  • 量身定制的抗凝策略,考虑到患者特异性因素和程序风险,是必不可少的.
  • 需要进一步的研究,以建立关于儿科ECMO抗凝药的最终共识建议.